1. Home
  2. LCFY vs CHEK Comparison

LCFY vs CHEK Comparison

Compare LCFY & CHEK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LCFY
  • CHEK
  • Stock Information
  • Founded
  • LCFY 2009
  • CHEK 2004
  • Country
  • LCFY Australia
  • CHEK Israel
  • Employees
  • LCFY N/A
  • CHEK N/A
  • Industry
  • LCFY
  • CHEK Medical Electronics
  • Sector
  • LCFY
  • CHEK Health Care
  • Exchange
  • LCFY Nasdaq
  • CHEK Nasdaq
  • Market Cap
  • LCFY 9.9M
  • CHEK 9.0M
  • IPO Year
  • LCFY 2022
  • CHEK 2015
  • Fundamental
  • Price
  • LCFY $7.48
  • CHEK $0.86
  • Analyst Decision
  • LCFY
  • CHEK
  • Analyst Count
  • LCFY 0
  • CHEK 0
  • Target Price
  • LCFY N/A
  • CHEK N/A
  • AVG Volume (30 Days)
  • LCFY 20.6K
  • CHEK 70.6K
  • Earning Date
  • LCFY 04-01-2025
  • CHEK 02-25-2025
  • Dividend Yield
  • LCFY N/A
  • CHEK N/A
  • EPS Growth
  • LCFY N/A
  • CHEK N/A
  • EPS
  • LCFY N/A
  • CHEK N/A
  • Revenue
  • LCFY $2,668,385.00
  • CHEK N/A
  • Revenue This Year
  • LCFY N/A
  • CHEK N/A
  • Revenue Next Year
  • LCFY N/A
  • CHEK N/A
  • P/E Ratio
  • LCFY N/A
  • CHEK N/A
  • Revenue Growth
  • LCFY N/A
  • CHEK N/A
  • 52 Week Low
  • LCFY $2.20
  • CHEK $0.56
  • 52 Week High
  • LCFY $11.23
  • CHEK $3.45
  • Technical
  • Relative Strength Index (RSI)
  • LCFY 49.98
  • CHEK 41.78
  • Support Level
  • LCFY $5.80
  • CHEK $0.81
  • Resistance Level
  • LCFY $8.00
  • CHEK $0.97
  • Average True Range (ATR)
  • LCFY 0.67
  • CHEK 0.10
  • MACD
  • LCFY -0.11
  • CHEK -0.02
  • Stochastic Oscillator
  • LCFY 46.80
  • CHEK 13.42

About LCFY Locafy Limited

Locafy Ltd is focused on commercializing its Software as a Service (SaaS) online publishing technology platform. Its platform enables the ability to publish almost any type of content to almost any device that uses a web browser to display web content. The firm has two operating segments: Publishing and SEO agency. Under the Publishing segment are products and services that the Company offers that are related to digital properties (i.e. mastheads) that it owns e.g. business data published on Hotfrog, advertising placed on AussieWeb, articles published on scoop.com.au. In contrast, under the SEO Agency segment are products and services that are applied to digital properties that are owned and operated by third parties. It derives a majority of its revenue in North America from SEO Agency.

About CHEK Check-Cap Ltd.

Check-Cap Ltd is a clinical-stage medical diagnostics company engaged in the development of an ingestible imaging capsule that utilizes low-dose X-rays for the detection and imaging of colonic polyps and colorectal cancers, or CRC. The company is developing C-Scan, the first capsule-based system for preparation-free, colorectal cancer screening. Its scanning capsule will be swallowed and propelled by natural motility through the gastrointestinal tract and excreted naturally with no need for retrieval for data collection. The operations of the company are presently located in Israel, but it currently expects to market products in the United States, Europe, Israel and Japan.

Share on Social Networks: